PDF(Pubmed)
Abstract：
The widely accepted option for treating traumatic direct carotid-cavernous fistula (dCCF) has been endovascular treatment using detachable balloons, coils, or embolic agents. Covered stent deployment has been applied by a few operators and has shown promising results. This is a retrospective study on patients with dCCF treated by an endovascular approach using BeGraft, a covered stent. In 4 cases, this device was successfully deployed without any complications. Immediate complete occlusion was achieved in 3 patients (75%) after deployment of the covered stents. One patient required transvenous coiling for occlusion of the remaining endoleak. Follow-up imaging demonstrated 100% fistula occlusion with complete internal carotid artery patency. No early or late complications occurred following treatment. In conclusion, the BeGraft-covered stent could be a promising safe and effective alternative option for the endovascular treatment of dCCF.
摘要：
广泛接受的治疗外伤性直接颈动脉海绵窦瘘（dCCF）的选择是使用可拆卸球囊进行血管内治疗，线圈,或栓塞剂。覆盖支架展开已被一些操作者应用,并且已显示出有希望的结果。这是对使用Begraft的血管内方法治疗的dCCF患者的回顾性研究，覆膜支架。在4个案例中，该装置成功部署，没有任何并发症。展开覆膜支架后，3例患者（75％）立即完全闭塞。一名患者需要经静脉卷绕以闭塞剩余的内漏。随访成像显示100％瘘闭塞，颈内动脉完全通畅。治疗后无早期或晚期并发症发生。总之,Begraft覆膜支架可能是dCCF血管内治疗的一种有前景的安全有效的替代选择.
